These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 14679886)

  • 21. Metformin: effects on cardiovascular risk factors in patients with non-insulin-dependent diabetes mellitus.
    Palumbo PJ
    J Diabetes Complications; 1998; 12(2):110-9. PubMed ID: 9559489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Type II diabetes mellitus.
    Edelman SV
    Adv Intern Med; 1998; 43():449-500. PubMed ID: 9506190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of short-term metformin treatment on insulin sensitivity of blood glucose and free fatty acids.
    Iannello S; Camuto M; Cavaleri A; Milazzo P; Pisano MG; Bellomia D; Belfiore F
    Diabetes Obes Metab; 2004 Jan; 6(1):8-15. PubMed ID: 14686957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Insulin-sensitizing agents: metformin and thiazolidinedione derivatives].
    Satoh J
    Nihon Rinsho; 2003 Jul; 61(7):1224-9. PubMed ID: 12877089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin action enhancers for the management of type 2 diabetes mellitus.
    Valsamakis G; Kumar S
    Expert Opin Pharmacother; 2000 Dec; 1(7):1413-21. PubMed ID: 11249474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent advances in the pharmacologic management of diabetes mellitus.
    Carlton FB
    Emerg Med Clin North Am; 2000 Nov; 18(4):745-53. PubMed ID: 11130936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacologic therapy for type 2 diabetes mellitus.
    DeFronzo RA
    Ann Intern Med; 1999 Aug; 131(4):281-303. PubMed ID: 10454950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Do effects on blood pressure contribute to improved clinical outcomes with metformin?
    Schäfers RF
    Diabetes Metab; 2003 Sep; 29(4 Pt 2):6S62-70. PubMed ID: 14502102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of biphasic insulin aspart 70/30 versus exenatide in subjects with type 2 diabetes failing to achieve glycemic control with metformin and a sulfonylurea.
    Bergenstal R; Lewin A; Bailey T; Chang D; Gylvin T; Roberts V;
    Curr Med Res Opin; 2009 Jan; 25(1):65-75. PubMed ID: 19210140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin sensitisation in the treatment of Type 2 diabetes.
    Tadayyon M; Smith SA
    Expert Opin Investig Drugs; 2003 Mar; 12(3):307-24. PubMed ID: 12605557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus.
    Hemmingsen B; Lund SS; Gluud C; Vaag A; Almdal TP; Hemmingsen C; Wetterslev J
    Cochrane Database Syst Rev; 2013 Nov; (11):CD008143. PubMed ID: 24214280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Impact of intensive blood glucose control with hypoglycemic sulfamides, metformin or insulin on complications of non-insulin dependent diabetes].
    André P
    Rev Epidemiol Sante Publique; 1999 Mar; 47(1):93-5. PubMed ID: 10214683
    [No Abstract]   [Full Text] [Related]  

  • 33. Potential contribution of metformin to the management of cardiovascular disease risk in patients with abdominal obesity, the metabolic syndrome and type 2 diabetes.
    Després JP
    Diabetes Metab; 2003 Sep; 29(4 Pt 2):6S53-61. PubMed ID: 14502101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Type 2 diabetes and metformin. First choice for monotherapy: weak evidence of efficacy but well-known and acceptable adverse effects.
    Prescrire Int; 2014 Nov; 23(154):269-72. PubMed ID: 25954799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes.
    Johnson JA; Majumdar SR; Simpson SH; Toth EL
    Diabetes Care; 2002 Dec; 25(12):2244-8. PubMed ID: 12453968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
    Freemark M; Bursey D
    Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of metformin in patients with poorly controlled, insulin-treated type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial.
    Avilés-Santa L; Sinding J; Raskin P
    Ann Intern Med; 1999 Aug; 131(3):182-8. PubMed ID: 10428734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Not Available].
    Viardot A
    Ther Umsch; 2017; 74(8):423-431. PubMed ID: 29461148
    [No Abstract]   [Full Text] [Related]  

  • 39. Metformin, a promising oral antihyperglycemic for the treatment of noninsulin-dependent diabetes mellitus.
    Wildasin EM; Skaar DJ; Kirchain WR; Hulse M
    Pharmacotherapy; 1997; 17(1):62-73. PubMed ID: 9017766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of metformin during pregnancy in women with gestational diabetes mellitus or polycystic ovary syndrome: a systematic review.
    Lautatzis ME; Goulis DG; Vrontakis M
    Metabolism; 2013 Nov; 62(11):1522-34. PubMed ID: 23886298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.